Brief: XORTX Provides Update On Acquisition Of Renal Anti-Fibrotic Therapeutic Program From Vectus Biosystems
04/02/2026 23:01
Feb 4 (Reuters) - XORTX Therapeutics Inc XRTX.V: XORTX PROVIDES UPDATE ON ACQUISITION OF RENAL ANTI-FIBROTIC THERAPEUTIC PROGRAM FROM VECTUS BIOSYSTEMS XORTX THERAPEUTICS INC - ACQUISITION CLOSING EXTENDED TO MARCH 31, 2026 Source text: ID:nGNX16NPRL Further company coverage: XRTX.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering